Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-11

Clinical Trial Update: Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women At Higher Risk [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating tranexamic acid to prevent heavy bleeding after childbirth in high-risk women is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Postpartum Hemorrhage | Phase 3 | Status: RECRUITING